Detalles de la búsqueda
1.
Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma®) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System.
Pharmaceuticals (Basel)
; 17(3)2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38543180
2.
Hyaluronic acid-based fillers in patients with autoimmune inflammatory diseases.
J Cosmet Dermatol
; 22(9): 2420-2423, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37128806
3.
Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years.
Front Immunol
; 14: 1134436, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37006303
4.
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study.
Front Immunol
; 13: 965171, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36263025
5.
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data.
Front Oncol
; 12: 824511, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35372076
6.
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database.
Front Pharmacol
; 11: 830, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32581796
Resultados
1 -
6
de 6
1
Próxima >
>>